Artivion

Artivion is a prominent global medical technology company specializing in innovative solutions for the treatment of aortic disease. The firm focuses on the development, manufacturing, and distribution of high-quality cardiac and vascular devices. Their extensive product portfolio includes heart valves, stent grafts, surgical sealants, and implantable human tissues. By partnering with surgeons worldwide, Artivion delivers advanced technologies designed to improve patient outcomes and address complex cardiovascular conditions.

Operating with a robust infrastructure, Artivion maintains a significant market presence with 3 global locations. The company supports a workforce of 1,000-5,000 employees dedicated to engineering and manufacturing excellence. With an annual revenue of $471.5M, the organization demonstrates strong financial performance within the medical devices and equipment sector. Their commitment to innovation is reflected in their diverse range of implantable medical devices and surgical tools, which are essential for modern cardiovascular procedures.

Artivion competes with various entities in the medical technology space, including Akumin and Alaska Heart & Vascular Institute. The company, which trades under the ticker NYSE: AORT, continues to expand its influence in the global healthcare market. Meet Artivion's team to learn more about the leadership and organizational structure driving their mission. Through strategic partnerships and a focus on high-quality manufacturing, Artivion remains a key player in the medical device industry, consistently advancing the standard of care for patients suffering from aortic disease.